You're right Salty, daily volumes are still too erratic to confirm probabilities but the overall basic picture - the way I see it - is worth considering: - long term support seems confirmed - Bollinger squeeze with narrowing range 1.8/2.1 - triangle pattern coming to a corner Fundamentally there 's the issue of a probable CR coming up in the next quarter and appearing as an undisputable necessity to most for the running of the clinical trial of next year but it's also worth recalling that the majority of licencing deals for biologics are made at the pre-clinical stage. There's the general meeting coming up and some issues may be addressed then.
